Huntingtin distribution among striatal output neurons of normal rat brain

Neuroscience Letters

Volumn 339, Issue 1, 2003, Pages 53-56

  Fusco, Francesca R ^a   Martorana, Alessandro ^a,b   De March, Zena ^a   Viscomi, Maria Teresa ^a   Sancesario, Giuseppe ^a,b   Bernardi, Giorgio ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Huntingtin; Huntington's disease; Striatal output neurons; Striatum

Indexed keywords

CANNABINOID 1 RECEPTOR; DOPAMINE 1 RECEPTOR; ENKEPHALIN; HUNTINGTIN; SUBSTANCE P;

ANIMAL TISSUE; ARTICLE; BRAIN; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; HUNTINGTON CHOREA; IMMUNOFLUORESCENCE; MALE; MUTATION; NERVE CELL; NERVE PROJECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RAT; TELENCEPHALON;

EID: 0037435383     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01474-X     Document Type: Article

References (20)

1. Albin R.L. Selective neurodegeneration in Huntington's disease. Ann. Neurol. 38:1995;835-836.
2. Bruyn G.W., Went L.N. Huntington's chorea. Vinken P.J., Bruyn G.W., Kiawans H.E. Handbook of Clinical Neurology Handbook of Clinical Neurology: 1986;267-313 Elsevier, Amsterdam.
3. Ferrante R.J., Kowall N.W., Beat M.F., Richardson E.P. Jr, Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 230:1985;561-563.
4. Fusco F.R., Chen Q., Lamoreaux W.J., Figueredo-Cardenas G., Jiao Y., Coffman J.A., Surmeier D.J., Honig M.G., Carlock L.R., Reiner A. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci. 19:1999;1189-1202.
5. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
6. Glass M., Dragunow M., Faull R.L. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience. 97:2000;505-519.
7. Gutekunst C.A., Levey A.I., Heilman C.J., Whaley W.L., Yi H., Nash N.R., Rees H.D., Madden J.J., Hersch S.M. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl. Acad. Sci. USA. 92:1995;8710-8714.
8. Kosinski C.M., Cha J.H., Young A.B., Persichetti F., MacDonald M., Gusella J.F., Penney J.B. Jr, Standaert D.G. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp. Neurol. 144:1997;239-247.
9. Landwehrmeyer G.B., McNeil S.M., Dure L.S., Ge P., Aizawa H., Huang Q., Ambrose C.M., Duyao M.P., Bird E.D., Bonilla E. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann. Neurol. 37:1995;218-230.
10. Lastres-Becker I., Berrendero F., Lucas J.J., Martin-Aparicio E., Yamamoto A., Ramos J.A., Fernandez-Ruiz J.J. Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB(1) receptors in the basal ganglia of a transgenic model of Huntington's disease. Brain Res. 929:2002;236-242.
11. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
12. Mailleux P., Vanderhaeghen J.J. Localization of cannabinoid receptor in the human developing and adult basal ganglia, higher levels in the striatonigral neurons. Neurosci. Lett. 148:1992;173-176.
13. Menalled L., Zanjani H., MacKenzie L., Koppel A., Carpenter E., Zeitlin S., Chesselet M.F. Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Exp. Neurol. 162:2000;328-342.
14. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. USA. 85:1988;5733-5737.
15. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney I., Vonsattel J.P., Aronin N., DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42:1997;604-612.
16. Steiner H., Bonner T.I., Zimmer A.M., Kitai S.T., Zimmer A. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice. Proc. Natl. Acad. Sci. USA. 96:1999;5786-5790.
17. Sugimoto T., Mizuno N. Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: an immunohistochemical study in the cat. J. Comp. Neurol. 257:1987;383-395.
18. Surmeier D.J., Song W.J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16:1996;6579-6591.
19. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
20. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Jr. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577.